Publication related to RSI or an RSI staff member

Burden of neurological conditions in Canada.

Neurological conditions are among the leading causes of disability in the Canadian population and are associated with a large public health burden. An increase in life expectancy and a declining birth rate has resulted in an aging Canadian population, and the proportion of age-adjusted mortality due to non-communicable diseases has been steadily increasing. These conditions are frequently associated with chronic disability and an increasing burden of care for patients, their families and caregivers. The National Population Health Study of Neurological Conditions (NPHSNC) aims to improve knowledge about neurological conditions and their impacts on individuals, their families, caregivers and health care system. The Systematic Review of Determinants of Neurological Conditions, a specific objective within the NPHSNC, is a compendium of systematic reviews on risk factors affecting onset and progression of the following 14 priority neurological conditions: Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS), brain tumours (BT), cerebral palsy (CP), dystonia, epilepsy, Huntington’s disease (HD), hydrocephalus, multiple sclerosis (MS), muscular dystrophies (MD), neurotrauma, Parkinson’s disease (PD), spina bifida (SB), and Tourette’s syndrome (TS). The burden of neurological disease is expected to increase as the population ages, and this trend is presented in greater detail for Alzheimer’s and Parkinson’s disease because the incidence of these two common neurological diseases increases significantly with age over 65 years. This article provides an overview of burden of neurological diseases in Canada to set the stage for the in-depth systematic reviews of the 14 priority neurological conditions presented in subsequent articles in this issue.

Authors

  • Gaskin, J, Gaskin J, McLaughlin Center for Population Health Risk Assessment, University of Ottawa, Ottawa, ON, Canada; Department of Epidemiology and Community Medicine, Faculty of Medicine, University of Ottawa, ON, Canada. Electronic address: jgaskin@uottawa.ca.

  • Gomes, J, Gomes J, McLaughlin Center for Population Health Risk Assessment, University of Ottawa, Ottawa, ON, Canada; Interdisciplinary School of Health Sciences, Faculty of Health Sciences, University of Ottawa, ON, Canada; Environmental Health Research Unit, University of Ottawa, ON, Canada.

  • Darshan, S, Darshan S, McLaughlin Center for Population Health Risk Assessment, University of Ottawa, Ottawa, ON, Canada.

  • Krewski, D, Krewski D, McLaughlin Center for Population Health Risk Assessment, University of Ottawa, Ottawa, ON, Canada; Department of Epidemiology and Community Medicine, Faculty of Medicine, University of Ottawa, ON, Canada; Risk Sciences International, Ottawa, ON, Canada.

YEAR OF PUBLICATION: 2017
SOURCE: Neurotoxicology. 2017 Jul;61:2-10. doi: 10.1016/j.neuro.2016.05.001. Epub 2016 May 3.
JOURNAL TITLE ABBREVIATION: Neurotoxicology
JOURNAL TITLE: Neurotoxicology
ISSN: 1872-9711 (Electronic) 0161-813X (Linking)
VOLUME: 61
PAGES: 2-10
PLACE OF PUBLICATION: Netherlands
ABSTRACT:
Neurological conditions are among the leading causes of disability in the Canadian population and are associated with a large public health burden. An increase in life expectancy and a declining birth rate has resulted in an aging Canadian population, and the proportion of age-adjusted mortality due to non-communicable diseases has been steadily increasing. These conditions are frequently associated with chronic disability and an increasing burden of care for patients, their families and caregivers. The National Population Health Study of Neurological Conditions (NPHSNC) aims to improve knowledge about neurological conditions and their impacts on individuals, their families, caregivers and health care system. The Systematic Review of Determinants of Neurological Conditions, a specific objective within the NPHSNC, is a compendium of systematic reviews on risk factors affecting onset and progression of the following 14 priority neurological conditions: Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), brain tumours (BT), cerebral palsy (CP), dystonia, epilepsy, Huntington's disease (HD), hydrocephalus, multiple sclerosis (MS), muscular dystrophies (MD), neurotrauma, Parkinson's disease (PD), spina bifida (SB), and Tourette's syndrome (TS). The burden of neurological disease is expected to increase as the population ages, and this trend is presented in greater detail for Alzheimer's and Parkinson's disease because the incidence of these two common neurological diseases increases significantly with age over 65 years. This article provides an overview of burden of neurological diseases in Canada to set the stage for the in-depth systematic reviews of the 14 priority neurological conditions presented in subsequent articles in this issue.
COPYRIGHT INFORMATION: Copyright (c) 2016. Published by Elsevier B.V.
LANGUAGE: eng
DATE OF PUBLICATION: 2017 Jul
DATE OF ELECTRONIC PUBLICATION: 20160503
DATE COMPLETED: 20180508
DATE REVISED: 20180508
MESH DATE: 2018/05/09 06:00
EDAT: 2016/05/08 06:00
STATUS: MEDLINE
PUBLICATION STATUS: ppublish
LOCATION IDENTIFIER: S0161-813X(16)30066-3 [pii] 10.1016/j.neuro.2016.05.001 [doi]
OWNER: NLM

Related RSI Experts

Daniel Krewski

Chief Risk Scientist

Dr. Daniel Krewski is Chief Risk Scientist and co-founder of Risk Sciences International (RSI), a firm established in 2006 to bring evidence-based, multidisciplinary expertise to the challenge of understanding, managing, and communicating risk. As RSI’s inaugural CEO and long-time scientific...
Read More about Daniel Krewski